ArticleACS medicinal chemistry letters2022

Novel Tricyclic Heteroaryl Compounds as IRAK4 Inhibitors for Treating Cancer, Autoimmune and Inflammatory Diseases.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.